Skip to content

MDCXW MEDICUS PHARMA LTD

Follow

*W EXP 11/15/202 (warrant or right), issuer CIK 1997296

5 managers (5 13F filers) reported a position in MDCXW shares at 2025-12-31, 170,100 shares in all. 0 filers opened a position and 1 filer sold out during the quarter.

Managers
5
13F filers
5
New
0
Added
1
Reduced
0
Sold out
1
Shares held by filers
170,100

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2025

Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Anson Funds Management LPin group Anson Funds Management LP42,400$64.9K0.01%013F-HRTimelineGroup
ARMISTICE CAPITAL, LLC60,600$48.5K<0.01%013F-HRTimeline
Private Advisor Group, LLC49,000$39.2K<0.01%+5,00013F-HRTimeline
Empery Asset Management, LP12,100$9.68K0.01%13F-HRTimeline
Connective Capital Management, LLC6,000$4.8K<0.01%013F-HRTimeline